L Chi Selected Research

L Chi Research Topics

Disease

4	Thrombosis (Thrombus) 04/2006 - 03/2000
2	Pain (Aches) 01/2018 - 08/2000
2	Neoplasms (Cancer) 02/2015 - 09/2000
2	Inflammation (Inflammations) 05/2001 - 04/2001
1	Idiopathic Pulmonary Fibrosis 09/2019
1	Rheumatic Diseases (Rheumatism) 01/2017
1	Spondylarthropathies 01/2017
1	Systemic Vasculitis 01/2017
1	Behcet Syndrome (Behcet's Syndrome) 01/2017
1	Uveitis 01/2017
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2017
1	Breast Neoplasms (Breast Cancer) 02/2015
1	Hypertrophy 12/2013
1	Rhinitis 07/2011
1	Asthma (Bronchial Asthma) 07/2011
1	Albuminuria 11/2007
1	Hypertension (High Blood Pressure) 11/2007
1	Kidney Diseases (Kidney Disease) 11/2007
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 02/2007
1	Spinal Cord Compression 04/2005
1	Spinal Cord Injuries (Spinal Cord Injury) 04/2005
1	Atherosclerotic Plaque (Atheroma) 01/2004
1	Acute Coronary Syndrome 01/2004
1	Ischemia 01/2004
1	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 10/2001
1	Weight Loss (Weight Reduction) 05/2001
1	Reperfusion Injury 10/2000
1	Edema (Dropsy) 10/2000
1	Infections 09/2000
1	Sickle Cell Anemia (Hemoglobin S Disease) 09/2000
1	Postoperative Pain 08/2000
1	Hemophilia A (Haemophilia) 03/2000

Drug/Important Bio-Agent (IBA)

3	Thrombin FDA Link 04/2006 - 02/2001
2	AntigensIBA 01/2017 - 01/2004
2	argatroban (MPQA)FDA Link 04/2006 - 01/2004
2	EnzymesIBA 04/2006 - 04/2005
2	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2005 - 01/2004
2	Messenger RNA (mRNA)IBA 01/2004 - 05/2001
2	Pharmaceutical PreparationsIBA 09/2000 - 03/2000
1	Bleomycin (Blenoxane)FDA LinkGeneric 09/2019
1	GlycosaminoglycansIBA 01/2018
1	Proteoglycans (Proteoglycan)IBA 01/2018
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2017
1	AntibodiesIBA 01/2017
1	Antinuclear AntibodiesIBA 01/2017
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2017
1	CateninsIBA 02/2015
1	cardamoninIBA 02/2015
1	Toll-Like Receptor 3IBA 02/2015
1	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2015
1	CollagenIBA 12/2013
1	Peptides (Polypeptides)IBA 12/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2011
1	Glutathione (Reduced Glutathione)IBA 02/2007
1	Blood Coagulation Factors (Coagulation Factor)IBA 04/2006
1	PD0313052IBA 04/2006
1	AntioxidantsIBA 04/2005
1	NF-kappa B (NF-kB)IBA 04/2005
1	Cytochromes c (Cytochrome c)IBA 04/2005
1	Caspase 3 (Caspase-3)IBA 04/2005
1	CholesterolIBA 01/2004
1	Factor VIIa (Activated Factor VII)IBA 01/2004
1	CoagulantsIBA 01/2004
1	Factor Xa InhibitorsIBA 01/2004
1	Proteins (Proteins, Gene)FDA Link 01/2004
1	Thromboplastin (Tissue Factor)IBA 01/2004
1	dendronIBA 10/2001
1	Sulfhydryl Compounds (Thiols)IBA 10/2001
1	Estrogen Receptor alphaIBA 05/2001
1	Histamine (Histamine Dihydrochloride)FDA Link 05/2001
1	Peptide Hydrolases (Proteases)FDA Link 04/2001
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2001
1	inogatranIBA 02/2001
1	LB 30057IBA 02/2001
1	Oxygen (Dioxygen)IBA 10/2000
1	Hydroxyurea (Hydrea)FDA LinkGeneric 09/2000
1	Morphine (MS Contin)FDA LinkGeneric 08/2000
1	Sufentanil (Sufenta)FDA LinkGeneric 08/2000
1	General AnestheticsIBA 08/2000
1	Analgesics (Analgesic Drugs)IBA 08/2000
1	Desflurane (I 653)FDA Link 08/2000
1	Remifentanil (Ultiva)FDA Link 08/2000
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 03/2000

Therapy/Procedure

4	Therapeutics 02/2015 - 03/2000
1	Nephrectomy 11/2007
1	Catheters 01/2004
1	Anesthesia 08/2000
1	Pain Management 08/2000